ライフサイエンスコーパス: immunoglobulin M

1 min, immunoglobulin A, immunoglobulin G, and immunoglobulin M).

2 as used to screen serum samples for anti-CMV immunoglobulin M.

3 red among 54%, but only 3% were positive for immunoglobulin M.

4 IL-7R and EBF but not B220, and can produce immunoglobulin M.

5 ng antibody and T-cell-independent antiviral immunoglobulin M.

6 uction of early T-cell-independent antiviral immunoglobulin M.

7 of the CSF samples tested positive for ZIKV immunoglobulin M.

8 globulins enriched with immunoglobulin A and immunoglobulin M (250 mg/kg, intravenous).

9 Immunoglobulin M 4,500 mg/dL or greater, bone marrow lym

10 Fetal immunoglobulin M against oral pathogens was detected in

11 azards model using bone marrow infiltration, immunoglobulin M, albumin, and beta-2 microglobulin valu

12 globulins enriched with immunoglobulin A and immunoglobulin M alleviated the symptoms of sickness beh

13 ox/lox)-CD19(+/Cre) mice have an increase in immunoglobulin M and CD43 and a decrease in CD5 expressi

14 Herein we demonstrate that immunoglobulin M and complement-opsonized Brucella abort

15 ent assay for anti-HCMV immunoglobulin G and immunoglobulin M and for cIL-10 and vIL-10 levels using

16 Complement-fixing antibodies and immunoglobulin M and G (IgM and IgG), targeting 3 distin

17 n in 67% and complement fixation in 70%, and immunoglobulin M and G antibodies were demonstrated by e

18 pairing that significantly increases primary immunoglobulin M and IgG responses to TI-2 Ags as well a

19 immune markers of mortality, while anti-LVS immunoglobulin M and IL-1beta were associated with survi

20 r periorbital edema and Trichinella-specific immunoglobulin M and immunoglobulin G antibodies after e

21 coronavirus 2 was positive in 33.6%, whereas immunoglobulin M and immunoglobulin G antibodies were po

22 tion, and intrathecal synthesis of borrelial immunoglobulin M and immunoglobulin G antibody in 100%,

23 Serum Borrelia immunoglobulin M and immunoglobulin G at the time of pos

24 ces of galactose expression or deposition of immunoglobulin M and immunoglobulin G were found in xeno

25 LD), an enzyme immunoassay (EIA) followed by immunoglobulin M and immunoglobulin G Western blots, per

26 it is characterized by low levels of surface immunoglobulin M and impairment of calcium mobilization

27 (-) T cells, and decreases in elevated serum immunoglobulin M and inflammatory markers including inte

28 gulated the expression of cell surface CD22, immunoglobulin M and major histocompatibility complex cl

29 eroprevalence of ZIKV was 6.2% based on ZIKV immunoglobulin M and negative for dengue reactivity.

30 Immunoglobulin M and/or G borrelial serum antibodies wer

31 e confirmed by detection of measles-specific immunoglobulin M and/or RNA.

32 6 or more days after symptom onset (and the immunoglobulins M and G in all 33 samples collected at l

33 d human serum protein, immunoglobulin G, and immunoglobulin M), and demonstrated a high correlation w

34 iters of serum and cerebrospinal fluid (CSF) immunoglobulin M, and occasionally positive results of W

35 circulating transitional B cells, increased immunoglobulin M, and reduced immunoglobulin G2 levels i

36 increased proliferation in response to anti-immunoglobulin M, anti-CD40, and lipopolysaccharide.

37 on, we found that Ad is opsonized by natural immunoglobulin M antibodies and complement and that thes

38 sult); and 17 had only positive findings for immunoglobulin M antibodies and did not meet the definit

39 o-treat autoimmune hemolytic anemia in which immunoglobulin M antibodies bind to erythrocytes and fix

40 Interestingly, natural immunoglobulin M antibodies bound to virus, which trigge

41 dults were examined for immunoglobulin G and immunoglobulin M antibodies for HEV.

42 Anti-Chlamydophila immunoglobulin M antibodies in Chlamydophila PCR-positiv

43 Infection was confirmed by immunoglobulin M antibodies or ANDV RNA in blood.

44 Being positive for anticardiolipin immunoglobulin M antibodies was a risk factor for any pl

45 in G antibodies, and sometimes low levels of immunoglobulin M antibodies, to Borrelia burgdorferi (Bb

46 s kill stimulated cells in synergy with anti-immunoglobulin M antibodies.

47 donors identified with early WNV infection (immunoglobulin M antibody negative) and those with uncon

48 eness and similarly prevented donor-specific immunoglobulin M antibody production.

49 ble case required fever and a positive rapid immunoglobulin M antibody test for typhoid (TUBEX TF); a

50 Immunoglobulin M antibody testing of serum specimens and

51 in the United States, confirmed by high ZIKV immunoglobulin M antibody titers in serum and cerebrospi

52 he infection when low levels of neutralizing immunoglobulin M antibody were detected in wild-type mic

53 fected CD28(-/-) mice produced primarily the immunoglobulin M antibody, which upon passive transfer p

54 termined that the measurement of Mp-specific immunoglobulin M antibody-secreting cells (ASCs) by enzy

55 ipid rafts in response to ligation with anti-immunoglobulin M (as a surrogate for antigen) are featur

56 and 92% agreement with the anti-VCA IgG and immunoglobulin M assays.

57 In cold agglutinin disease (CAD), immunoglobulin M autoantibodies fix complement on the su

58 IL-21 integrated signals mediated by surface immunoglobulin M (B-cell receptor) and Toll-like recepto

59 previously unidentified and unique subset of immunoglobulin M(+) B cells that present with an AA4.1(-

60 vation of cells lacking ASF/SF2 through anti-immunoglobulin M-B-cell receptor cross-linking rescued v

61 h Laboratory (VDRL) test and a specific IgM (immunoglobulin M) capture enzyme-linked immunosorbent as

62 en VWF levels < 130 U/dL and both monoclonal immunoglobulin M concentration (mIgMC) and viscosity.

63 urrence with these findings, postvaccination immunoglobulin M concentrations were not significantly i

64 oint swelling and higher anti-B. burgdorferi immunoglobulin M cross-reactive responses than other str

65 At best response, median serum immunoglobulin M declined from 3,520 to 821 mg/dL, bone

66 -)), CD8-deficient (CD8(-/-)), and secretory immunoglobulin M-deficient (sIgM(-/-)) mice and wild-typ

67 IRI induces immunoglobulin M-dependent complement activation on endo

68 Immunoglobulin M detection provided no advantage in sens

69 The data indicate that immunoglobulin M detection tests have limited utility fo

70 hrough dengue nonstructural protein 1 and/or immunoglobulin M detection, were included in this study

71 to acute postinfectious cold hemagglutinin (immunoglobulin M) disease.

72 an lipopolysaccharide-binding protein (LBP), immunoglobulin M endotoxin core antibodies to lipopolysa

73 -time polymerase chain reaction (RT-PCR) and immunoglobulin M enzyme-linked immunosorbent assay testi

74 n, WNV-specific B cells were not detected by immunoglobulin M enzyme-linked immunospot analysis until

75 We identified the immunoglobulin M Fc receptor (FcmuR), also known as the

76 ding alpha/beta interferon (IFN-alpha/beta), immunoglobulin M, gammadelta T cells, and complement aga

77 infection (viral nonstructural protein 1 and immunoglobulin M) has greatly simplified laboratory-base

78 ed by inducible bulk expression of secretory immunoglobulin M heavy chain (mu(s)) thanks to the unfol

79 the stability of the alternatively expressed immunoglobulin M heavy chain secretory mRNA is developme

80 The immunoglobulin M heavy-chain locus contains two poly(A)

81 BV infection in nine cases of X-linked hyper-immunoglobulin M (hyper-IgM) syndrome who, due to a muta

82 We sought to characterize monoclonal immunoglobulin (M-Ig) light chains before clinical prese

83 ated transgenic zebrafish in which the major immunoglobulin M (IgM(+)) B-cell subset expresses green

84 To prevent immunoglobulin M (IgM) "flare," single agent bortezomib

85 MBC) response was mediated by both classical immunoglobulin M (IgM) (IgM(+)CD27(+)) and switched immu

86 Detection of donor-reactive immunoglobulin M (IgM) AECAs did not correlate with incr

87 uNP) labels functionalized with anti-Mtb LAM immunoglobulin M (IgM) and anti-Mtb LAM IgG respectively

88 ntial for generating acute pathogen-specific immunoglobulin M (IgM) and early IgG, which reduced path

89 nosorbent assays for anti-H. pylori-specific immunoglobulin M (IgM) and IgA established using bacteri

90 hose obtained by BLOTrix analysis of MarBlot immunoglobulin M (IgM) and IgG and by ViraScan analysis

91 immunosorbent assay (ELISA) that can detect immunoglobulin M (IgM) and IgG antibodies in patients wi

92 S21, stimulated the production of high-titer immunoglobulin M (IgM) and IgG antibodies.

93 The GM2-KLH/QS-21 vaccine induces high immunoglobulin M (IgM) and IgG antibody responses.

94 terize the nanoscale spatial organization of immunoglobulin M (IgM) and IgG BCRs on the surfaces of r

95 gingivalis CPS developed elevated levels of immunoglobulin M (IgM) and IgG in serum that reacted wit

96 Anti-PfGPI immunoglobulin M (IgM) and IgG levels were measured in 3

97 GC-dependent immune responses, reduces total immunoglobulin M (IgM) and IgG levels, and leads to incr

98 eatures, including continuous high titers of immunoglobulin M (IgM) and IgG reactivity throughout all

99 ssociated with higher brain CFU, lower serum immunoglobulin M (IgM) and IgG responses to glucuronoxyl

100 ocococcal pulmonary infection elicited serum immunoglobulin M (IgM) and IgG to the capsular polysacch

101 Antigen-specific immunoglobulin M (IgM) and IgG were produced to almost m

102 ritoneal B1 B cells, and correction of serum immunoglobulin M (IgM) and IgG(3) levels.

103 components of humoral immunity, particularly immunoglobulin M (IgM) and IgG, have critical roles in p

104 /-) mice produced low levels of WNV-specific immunoglobulin M (IgM) and IgG, viral clearance from the

105 markedly reduced levels of specific anti-WNV immunoglobulin M (IgM) and IgG.

106 se sensitivity and permit the measurement of immunoglobulin M (IgM) and immunoglobulin G (IgG) classe

107 ZIKV-NS1 immunoglobulin M (IgM) and immunoglobulin G (IgG) ELISAs

108 ral immune response to NiV by virus-specific immunoglobulin M (IgM) and immunoglobulin G (IgG) enzyme

109 We examined immunoglobulin M (IgM) and immunoglobulin G (IgG) serolo

110 ) enzyme-linked immunosorbent assay (ELISA), immunoglobulin M (IgM) and immunoglobulin G (IgG) Wester

111 lyzed for (1) viral DNA loads, (2) anti-B19V immunoglobulin M (IgM) and immunoglobulin G (IgG), (3) a

112 gy prior to termination showed both specific immunoglobulin M (IgM) and immunoglobulin G (IgG), where

113 a positive correlation between BA plasma CMV immunoglobulin M (IgM) and liver T-cell CMV reactivity w

114 rated reporter and two endogenous rat genes, Immunoglobulin M (IgM) and Rab38, we demonstrate that a

115 y to such xenobiotics would be predominantly immunoglobulin M (IgM) and using sera from a large cohor

116 cted donors were viremic and/or positive for immunoglobulin M (IgM) and/or immunoglobulin G.

117 We investigated the pathogenicity of immunoglobulin M (IgM) anti-GM1 antibodies in serum from

118 Quantitative measurements of immunoglobulin M (IgM) anti-hepatitis B core antibody (a

119 Binding of immunoglobulin M (IgM) antibodies from normal human seru

120 We measured PS immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies in Malaysian patients

121 the identification of rubella virus-specific immunoglobulin M (IgM) antibodies in serum, but approxim

122 athies associated with persistently elevated immunoglobulin M (IgM) antibodies that react with GQ1b,

123 of persons with suspected HEV was tested for immunoglobulin M (IgM) antibodies to HEV to confirm infe

124 In mice, immunoglobulin M (IgM) antibodies to the DIII-lr epitope

125 tected SARS-CoV-2 immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies was undertaken under m

126 day prior to the onset of clinical disease; immunoglobulin M (IgM) antibodies were detected at low l

127 Anti-mumps virus immunoglobulin M (IgM) antibodies were detected using a

128 shown to induce the production of anti-oxLDL immunoglobulin M (IgM) antibodies, due to molecular mimi

129 Detection of CHIKV-specific immunoglobulin M (IgM) antibody becomes a sensitive test

130 Immunoglobulin M (IgM) antibody to the outbreak Lp6 stra

131 eguides for the detection of dengue-specific immunoglobulin M (IgM) antibody, and we demonstrate dete

132 ing-mouse brain WN virus antigen used in the immunoglobulin M (IgM) antibody-capture and indirect IgG

133 The use of immunoglobulin M (IgM) antibody-capture enzyme-linked im

134 onstructural protein 1 (NS1) in the standard immunoglobulin M (IgM) antibody-capture enzyme-linked im

135 The immunoglobulin M (IgM) antibody-capture enzyme-linked im

136 enzyme or crude lysates generated from anti-immunoglobulin M (IgM) antibody-treated RAMOS cells.

137 ies, but not the production of low-affinity, immunoglobulin M (IgM) antibody.

138 , we report that ST6Gal-I deficiency induces immunoglobulin M (IgM) antigen receptor endocytosis in t

139 ed by a selective pressure to retain surface immunoglobulin M (IgM) BCR despite an active class-switc

140 Between 5- and 10-fold more purified human immunoglobulin M (IgM) but not IgG was deposited onto ds

141 ptor for the crystallizable fragment (Fc) of immunoglobulin M (IgM) can function as a cell-surface re

142 Focus Technologies has developed an immunoglobulin M (IgM) capture enzyme-linked immunosorbe

143 y of undetermined significance (MGUS) of the immunoglobulin M (IgM) class, which progresses to lympho

144 lso displayed low Ki-67, CD49d, cell-surface immunoglobulin M (IgM) expression and IgM-signaling resp

145 ls in blood, and require rapid production of immunoglobulin M (IgM) for clearance.

146 Passive transfer of normal mouse serum, immunoglobulin M (IgM) from normal mouse serum, or IgG f

147 with encephalitis had orthopoxvirus-reactive immunoglobulin M (IgM) in cerebrospinal fluid.

148 rpretation of positive cytomegalovirus (CMV) immunoglobulin M (IgM) in the first trimester of pregnan

149 Immunoglobulin M (IgM) is an ancient antibody class that

150 previously demonstrated that clustering the immunoglobulin M (IgM) isotype of BCR with an artificial

151 An immunoglobulin M (IgM) kappa paraprotein was detected in

152 significantly higher and the endotoxin core immunoglobulin M (IgM) level lower in cases, compared wi

153 utations, severe B lymphopenia and decreased immunoglobulin M (IgM) levels were noted.

154 WNV-specific immunoglobulin M (IgM) levels were similar to those of w

155 l centers (GCs), yet it generates protective immunoglobulin M (IgM) memory B cells (MBCs) that expres

156 Immunoglobulin M (IgM) monoclonal antibodies to an epito

157 MYD88 L265P was absent in 90% of immunoglobulin M (IgM) monoclonal gammopathy of undeterm

158 lved in the pathogenesis of premalignant non-immunoglobulin M (IgM) monoclonal gammopathy of undeterm

159 Immunoglobulin M (IgM) natural antibodies bind oxidative

160 detect human parvovirus B19 (B19V)-specific immunoglobulin M (IgM) or IgG in the sera of 198 pregnan

161 AL amyloidosis associated with immunoglobulin M (IgM) paraproteinemia is rare.

162 enstrom macroglobulinemia (WM), which has an immunoglobulin M (IgM) paraproteinemia, is classified as

163 antibody library obtained from a human donor Immunoglobulin M (IgM) pool was determined to be at leas

164 % CI: 0.7-4.7%) for Epstein-Barr virus (EBV) immunoglobulin M (IgM) positivity, 94.7% (95% CI: 90.7-9

165 Both up-regulation of CD22 expression and immunoglobulin M (IgM) production, markers of CLL differ

166 lymphoma characterized by hypersecretion of immunoglobulin M (IgM) protein and tumor infiltration in

167 ltration of the bone marrow and a monoclonal immunoglobulin M (IgM) protein.

168 Odds ratios for high immunoglobulin M (IgM) reactivity to EBV-viral capsid an

169 (>/=7 days), respiratory manifestations, an immunoglobulin M (IgM) response in peripheral blood, and

170 to become activated and produce potent acute immunoglobulin M (IgM) responses.

171 cked VN activity; moreover, purified natural immunoglobulin M (IgM) restored VN activity to antibody-

172 A positive Toxoplasma immunoglobulin M (IgM) result is often interpreted as a

173 Positive immunoglobulin M (IgM) results are not sufficient as evi

174 infections and rule out misleading positive immunoglobulin M (IgM) results in areas with various lev

175 ation, loss of STAT5 significantly decreased immunoglobulin M (IgM) secretion.

176 Anti-dengue virus (DENV) immunoglobulin M (IgM) seroconversion has been the refer

177 Usually, immunoglobulin M (IgM) serologic analysis is not suffici

178 functional consequences of a single round of immunoglobulin M (IgM) signaling.

179 The hyper immunoglobulin M (IgM) syndrome (HIGM), characterized by

180 al control over high and sustained levels of immunoglobulin M (IgM) synthesis.

181 ompared the results of a serum-based measles immunoglobulin M (IgM) test with results of tests using

182 Mumps immunoglobulin M (IgM) testing was negative and reverse-

183 Although HSV-specific immunoglobulin M (IgM) titers were comparable for both B

184 1) integrins reduced B. burgdorferi-specific immunoglobulin M (IgM) titers, enhanced pathogen burden,

185 Immunoglobulin class switching from immunoglobulin M (IgM) to IgG and IgA is central to immu

186 t assay (ELISA) for the detection of chicken immunoglobulin M (IgM) to WN virus was developed, standa

187 re to oral pathogens was determined by fetal immunoglobulin M (IgM) umbilical cord seropositivity.

188 In Yaounde, Cameroon, parasite-specific immunoglobulin M (IgM) was detected in 14% of cord blood

189 globulinemia (MC), a monoclonal expansion of immunoglobulin M (IgM)(+) autoreactive B cells, and also

190 these primary immunodeficiencies have fewer immunoglobulin M (IgM)(+)IgD(+)CD27(+) B cells, a popula

191 V(+)MC(+) subjects have clonal expansions of immunoglobulin M (IgM)(+)kappa(+)IgD(low/-)CD21(low)CD27

192 Levels of total immunoglobulin G (IgG), immunoglobulin M (IgM), and IgG subtypes against the fol

193 a direct relationship between surface CD79B, immunoglobulin M (IgM), and IgM-induced signaling levels

194 kin lymphoma that features overproduction of immunoglobulin M (IgM), clearly has a familial component

195 des stercoralis was shown to be dependent on immunoglobulin M (IgM), complement activation, and granu

196 In 51p1-encoded immunoglobulin M (IgM), complementarity-determining regi

197 Plasma was analyzed for anti-HCV immunoglobulin M (IgM), cytokine/granzyme concentrations

198 enzyme-linked immunospot assay, we evaluated immunoglobulin M (IgM), IgA, and IgG antibody-secreting

199 serum or plasma samples were tested for WNV immunoglobulin M (IgM), IgA, and IgG by using enzyme-lin

200 accharide (PS) vaccines induce type-specific immunoglobulin M (IgM), IgG, and IgA.

201 All animals had high prechallenge levels of immunoglobulin M (IgM), IgG, IgG1, and IgG2 serum antibo

202 ell populations and reduced antigen-specific immunoglobulin M (IgM), IgG1, and IgG3 production.

203 , as well as higher concentrations of plasma immunoglobulin M (IgM), relative to individuals with the

204 WM) is characterized by an overproduction of immunoglobulin M (IgM), which can lead to a hyperviscosi

205 Recently, immunoglobulin M (IgM)-capture enzyme immunoassays for t

206 The four rapid tests were a microplate immunoglobulin M (IgM)-enzyme-linked immunosorbent assay

207 TgE Lyn(-/-) mice had a larger immunoglobulin M (IgM)-positive B-cell population than T

208 Immunoglobulin M (IgM)-related light chain (AL) amyloido

209 cretory antigen (TESA) blot for detection of immunoglobulin M (IgM)-specific shed acute phase antigen

210 on of EBV latency III LCL gene expression to immunoglobulin M (IgM)-stimulated B cells, germinal-cent

211 parenchyma to secrete polyreactive emergency immunoglobulin M (IgM).

212 gnals including the cross-linking of surface immunoglobulin M (IgM).

213 expansion accompanied by a serum monoclonal immunoglobulin M (IgM).

214 phoplasmacytic cells that produce monoclonal immunoglobulin M (IgM).

215 tion in bone marrow, lymph node development, immunoglobulin M (IgM)/IgG production, and humoral immun

216 Prototype immunoglobulin M (IgM)/immunoglobulin G (IgG) ELISAs wer

217 58.95; P = .001) and high levels of phase II immunoglobulin M (IgM; AHR, 6.59; 95% CI, 1.37-31.62; P

218 further into the immune response by studying immunoglobulin-M (IgM) and IgG subclass 3 (IgG3) DSA to

219 the mechanisms behind WM transformation from immunoglobulin-M (IgM) monoclonal gammopathy of undeterm

220 itudinal dynamics of immunoglobulin-G (IgG), immunoglobulin-M (IgM), and in vitro neutralizing antibo

221 njugates, but the Inaba-specific antibodies (immunoglobulin M [IgM] and IgG1) were neither vibriocida

222 mice produced human monoclonal paraprotein (immunoglobulin M [IgM] and/or kappa or lambda chain) det

223 (chronic ataxic neuropathy, ophthalmoplegia, immunoglobulin M [IgM] paraprotein, cold agglutinins, an

224 resistance of monoclonal antibodies B6.1 (an immunoglobulin M [IgM]) and C3.1 (an IgG3) against exper

225 e same HA copy number), the highest primary (immunoglobulin M [IgM]) and secondary (IgG) anti-HA humo

226 (sCD14) and endotoxin core antibody (EndoCAb immunoglobulin M [IgM]) in plasma.

227 use mice (transgenic mice that express human immunoglobulin M [IgM], IgG2, and kappa) which were immu

228 three populations: somatically hypermutated immunoglobulin M(+) (IgM(+)) and IgG(+) MBC subsets and

229 Soon after BLV injection, immunoglobulin M+ (IgM+) and CD8+ cells increased in eff

230 by persistent elevation of neutrophils, and immunoglobulin M+ (IgM+) B cells.

231 Serum levels of immunoglobulin M, immunoglobulin A, and immunoglobulin G

232 We tested cases' sera for measles immunoglobulin M, immunoglobulin G, avidity, and plaque

233 re stained for galactose-alpha1,3-galactose, immunoglobulin M, immunoglobulin G, complement, fibrin,

234 l enzyme-linked immunosorbent assay kits for immunoglobulin M/immunoglobulin G antibodies to herpes s

235 globulins enriched with immunoglobulin A and immunoglobulin M improve the integrity of the blood-brai

236 The antibody assay detected immunoglobulin M in 87% (52 of 60) COVID-19-positive ser

237 ction, comprising approximately 90% of serum immunoglobulin M in ATA micro kappa mice.

238 The identification of West Nile virus immunoglobulin M in cerebrospinal fluid is the recommend

239 detectable levels of immunoglobulin G and/or immunoglobulin M in human plasma samples after treatment

240 In Gp1, anti-A/B and cytotoxic anti-pig immunoglobulin-M increased steadily during the first yea

241 PF-04691502 inhibited both anti-immunoglobulin M-induced signaling and overcame stroma-i

242 Immunoglobulin M is an especially important product of t

243 CD19, along with immunoglobulin M, is down-regulated in the bone marrow u

244 s and secreting Stx1-specific Hu-MAbs (seven immunoglobulin M(kappa)() [IgM(kappa)] elements [one spe

245 8 pneumococcal capsular polysaccharide D11 [immunoglobulin M(kappa)] protects wild-type and compleme

246 h nonsense CXCR4 mutations have higher serum immunoglobulin M levels and incidence of symptomatic hyp

247 munity were associated with persistently low immunoglobulin M levels and lymphopenia, respectively.

248 w lower bone marrow disease burden and serum immunoglobulin M levels but show an increased risk of de

249 declined from 55% to 10% (P = .0004), serum immunoglobulin M levels declined from 4,830 to 1,115 mg/

250 bone marrow (BM) disease involvement, serum immunoglobulin-M levels, and symptomatic disease requiri

251 WILDTYPE (WT)) had intermediate BM and serum immunoglobulin-M levels; those with MYD88(WT)CXCR4(WT) s

252 enes (>5% deviation from germ line), surface immunoglobulin M ligation failed to induce receptor tran

253 derly individuals have a lower percentage of immunoglobulin M memory B cells than healthy young adult

254 t expression of the secretory heavy chain of immunoglobulin M (micros), is well-tolerated in HeLa cel

255 Two clonally related immunoglobulin M monoclonal Abs (MAbs) (12A1 and 13F1) d

256 DS Eligible patients had measurable disease (immunoglobulin M monoclonal protein > 1,000 mg/dL with >

257 mpared to those for a cohort of B19-specific immunoglobulin M-negative (IgM(-)), IgG(+) remotely infe

258 lored whether the presence of lipid-specific immunoglobulin M oligoclonal bands in cerebrospinal flui

259 globulins enriched with immunoglobulin A and immunoglobulin M on blood-brain barrier integrity and su

260 d B-PLL- showed best resemblance with normal immunoglobulin M-only B-cells.

261 Despite the lack of BB0405-specific immunoglobulin M or immunoglobulin G antibodies during n

262 he mice were incapable of Chlamydia-specific immunoglobulin M or immunoglobulin G production.

263 -SARS-CoV-2 serum antibodies showed positive immunoglobulin M or immunoglobulin G titers.

264 ld rise in serum levels of immunoglobulin A, immunoglobulin M, or immunoglobulin G.

265 globulins enriched with immunoglobulin A and immunoglobulin M (p < .01).

266 ients had significant increase in polyclonal immunoglobulin M (P = .005), indicating innate immune sy

267 rom their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to

268 urred in 62% of subjects, but only 0.3% were immunoglobulin M positive.

269 based on seroconversion for HCMV and/or HCMV immunoglobulin M-positive and low or moderate HCMV immun

270 se with HEV had evidence of recent exposure (immunoglobulin M-positive).

271 s (P < 0.05) were evident in CD4(+), CD8(+), immunoglobulin M-positive, and CD172a(+) cell fractions

272 Parvovirus B19 immunoglobulin M positivity was associated with a 71% in

273 serum samples were tested for parvovirus B19 immunoglobulin M positivity.

274 ttenuates lenalidomide-mediated increases in immunoglobulin M production by normal B cells.

275 obulin G, although they were not impaired in immunoglobulin M production relative to controls.

276 ned wave of signaling that promotes specific immunoglobulin M production.

277 >/=0.2 g/24 h), absence of intact monoclonal immunoglobulin (M protein) in the serum, and no evidence

278 (FLCs), soluble CD30 (sCD30), and monoclonal immunoglobulins (M-proteins).

279 unoglobulin G: r = 0.138, P = 0.031; anti-Vi immunoglobulin M: r = 0.197, P = 0.034).

280 Both immunoglobulin M receptor-induced Ca(2+) flux and prolif

281 globulins enriched with immunoglobulin A and immunoglobulin M, respectively (p < .01).

282 The immunoglobulin M response in previously vaccinated indiv

283 oincidently with the development of a modest immunoglobulin M response.

284 p10 were needed to generate a weak anti-p10 immunoglobulin M response.

285 erm persistence of anti-viral capsid antigen immunoglobulin M responses in children from the high-mal

286 1 to drive differentiation of splenocytes to immunoglobulin M-secreting cells.

287 versus postoutbreak sample, and near-farm by immunoglobulin M seroprevalence in a municipal populatio

288 B cells from apoptosis and increases surface immunoglobulin M (sIgM) expression on murine splenic B c

289 ates of anergy, indicated by reduced surface immunoglobulin M (sIgM) levels and signaling, consequent

290 ivation also correlated closely with surface immunoglobulin M (sIgM) signaling capacity in vitro in b

291 ps infection can be made by the detection of immunoglobulin M-specific antibodies to mumps virus in a

292 intracellular calcium that accompanies anti-immunoglobulin M stimulation, and this effect mediates t

293 TFE3 and TFEB in T cells resulted in a hyper-immunoglobulin M syndrome due to impaired expression of

294 l anti-HBc or anti-HBc immunoglobulin G (not immunoglobulin M) test should be used.

295 Immunoglobulin M testing was conducted on serologic samp

296 globulins enriched with immunoglobulin A and immunoglobulin M treatment, no ultrastructural evidence

297 Type V CPS-specific immunoglobulin M was a dominant isotype of immune respon

298 produced immunoglobulin G predominantly, but immunoglobulin M was predominant in younger children.

299 ain, immunoglobulin G, immunoglobulin A, and immunoglobulin M were measured on ICU days 1, 3, and 7.

300 in ZAP-70-positive CLL trigger secretion of immunoglobulin M, which then serves as (auto-) antigen f